Fred Alger Management, LLC Ascendis Pharma A/S Transaction History
Fred Alger Management, LLC
- $19.8 Billion
- Q3 2024
A detailed history of Fred Alger Management, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Fred Alger Management, LLC holds 258,210 shares of ASND stock, worth $33.4 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
258,210
Previous 307,073
15.91%
Holding current value
$33.4 Million
Previous $41.9 Million
7.92%
% of portfolio
0.19%
Previous 0.21%
Shares
12 transactions
Others Institutions Holding ASND
# of Institutions
244Shares Held
58.8MCall Options Held
250KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.25 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$663 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$645 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$570 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$541 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.21B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...